minocycline

(redirected from Solodyn)
Also found in: Dictionary, Thesaurus.

minocycline

 [mĭ-no-si´klēn]
a semisynthetic broad-spectrum antibiotic of the tetracycline group; administered orally or intravenously as the hydrochloride salt
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

minocycline

(mĭn′ə-sī′klēn′, -klĭn)
n.
A broad-spectrum antibiotic, C23H27N3O7, derived from tetracycline and used usually in the form of its hydrochloride.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

minocycline

A broad-spectrum tetracycline which has a longer serum half-life and achieves higher serum levels than simple tetracycline.

Indications
Acne, Lyme disease, MRSA, and other resistant microbes; it is also a recognised disease-modifying anti-rheumatic drug (DMARD).

Adverse effects
Vertigo, diarrhoea, patchy skin pigmentation, autoimmune disease.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

minocycline

A TETRACYCLINE antibiotic used to treat ACNE and general infections. Brand names are Aknemin and Minocin.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
References in periodicals archive ?
(153.) See In re Solodyn (Minocycline Hydrochloride) Antitrust
SOLODYN is indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older, added the company.
(101) Pursuant to the distribution agreement, Medicis agreed (i) to supply Impax with certain generic legacy strengths of Solodyn for approximately its cost to manufacture and (ii) to pay Impax a certain amount of sales profits in the United States.
Launched to dermatologists in July 2006 after approval by FDA on May 8, 2006, SOLODYN is the only branded oral minocycline approved for once daily dosage in the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
M2 PHARMA-February 21, 2018-Impax unveils authorised generic Solodyn (Minocycline HCl) extended-release tablets in the market
Arizona-based Medicis' portfolio includes acne treatment product Solodyn and Botox' competitor Dysport.
The Food and Drug Administration approved Solodyn (minocycline) extendedrelease tablets for treatment of inflammatory nonnodular moderate to severe acne vulgaris in patients 12 years of age and older.
Minocycline Hydrochloride Barr Laboratories Solodyn
Sales Rank Product 2009 dollar sales (bit.) 1 Oxycontin $2.90 2 Adderall XR 1.04 3 Proair HFA 0.91 4 Rebif 0.87 5 Metoprolol Succinate 0.81 6 Lovaza 0.76 7 Pantoprazole Sodium (Pfizer) 0.75 8 Androgel 1% 0.71 9 Amphetamin Salt ER 0.69 10 Pantoprazole Sodium (Teva) 0.56 11 Amlodipine Besylate/Benazepril 0.54 12 Solodyn 0.54 13 Fentanyl 0.49 14 Gamunex 0.43 15 Gammagard Liquid 0.43 16 Ocella 0.38 17 Divalproex Sodium ER 0.32 18 Carimune NF 0.28 19 Hydrocone APAP 0.28 20 Oxycodone HCI ER 0.27 Source: IMS Health